scPharmaceuticals

Green traffic light
Pharma

FDA approves Corstasis' nasal spray as treatment for edema

The FDA has approved Corstasis Therapeutics’ nasal spray Enbumyst to relieve the edema associated with heart failure and kidney and liver disease.
Kevin Dunleavy Sep 15, 2025 3:33pm
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

MannKind makes $360M M&A play for scPharmaceuticals

Aug 25, 2025 11:30am
money bills fundraise

ScPharmaceuticals raises $50M for launch of on-body infusor

Nov 22, 2022 10:40am
heart failure

FDA signs off on scPharmaceutical’s on-body infusor for HF

Oct 10, 2022 10:51am
FDA

ScPharmaceuticals gets decision date for twice-rejected therapy

May 17, 2022 9:40am
FDA Building 2

ScPharmaceuticals plots refiling of twice-rejected therapy

Mar 2, 2021 7:20am